Pharmacists and COVID-19: What You Need to Know Now

Visit the APhA Pharmacists' Guide to Coronavirus

News View all news

December 1, 2020

At emergency meeting, ACIP members could decide who gets first dibs on COVID-19 vaccine

Despite expectations that CDC’s Advisory Committee on Immunization Practices (ACIP) would make its COVID-19 vaccine allocation recommendations once one or more vaccines received FDA emergency use authorization (EUA)—the traditional timeline—the group will vote Tuesday, December 1, on a “Phase 1a” distribution strategy. ACIP convened the 2:00 pm ET December 1 emergency meeting to ensure its advice is available before FDA approves any EUAs; the agency is slated to consider the first application on December 10. U.S. Department of Health and Human Services Secretary Alex Azar has said that Operation Warp Speed will begin shipping COVID-19 vaccines to states within 24 hours of their approval.

December 1, 2020

Federal pharmacy gathers virtually for JFPS 2020

Roughly 750 participants tuned in for 2 days of virtual education, video chats, networking events, and more at the Joint Federal Pharmacy Seminar (JFPS) 2020 Virtual, held on November 13 and 14.

December 1, 2020

Moderna applies for emergency FDA approval for its coronavirus vaccine

Moderna announced Monday it has applied to FDA for emergency use authorization of its candidate COVID-19 vaccine. If approved, the company said, vaccinations could begin in the United States as soon as December 21. Moderna reported that complete data from a large study indicated the vaccine was 94.1% effective, confirming earlier estimates.

November 30, 2020

Pharmacies add freezers, train staff to handle COVID-19 vaccination drive

Supermarket pharmacies are gearing up to become major providers of COVID-19 vaccinations. Grocery stores say they are well-positioned to provide the vaccines because a large share of the population lives near one of their stores, and their pharmacies regularly offer vaccinations for other illnesses.

November 25, 2020

Shared clinical decision making important for MenB vaccines

CDC’s Advisory Committee on Immunization Practices (ACIP) has published its 2020 recommendations for meningococcal vaccination, which cover use of the three quadrivalent conjugate vaccines—meningococcal serotypes A, C, W, and Y (MenACWY)—and two available meningococcal serogroup B (MenB) vaccines. The recommendations call on shared clinical decision making for the MenB vaccine for adolescents and young adults ages 16 to 23 years and highlight the importance of these vaccines for patients at increased risk.

Students

Let APhA help you through your pharmacy training and beyond.

Learn More

New Practitioners

Your career starts here. Get the tools you need to kick-start your career.

Learn More

Pharmacists

Reach your full potential as a pharmacist with these helpful practice tools and resources.

Learn More

Pharmacy Technicians

Media/Press

Not a member? See What APhA can do for you

CEO Blog

by Scott Knoer

View all CEO blog posts

November 10, 2020

My statement on the presidential election

I want to share with you my statement on the presidential election. APhA will continue to inform you on our advocacy work before and after the inauguration. The statement: “The American Pharmacists…

Rutledge v PCMA arguments: Thumbs up or thumbs down?

For today’s blog, I invited Ilisa Bernstein, APhA’s senior vice president for pharmacy practice and government affairs, to share her thoughts on this week’s big Supreme Court case from her…

Press Releases

View all press releases

December 1, 2020

American Pharmacists Association Announces Recipients of 2021 Academy Awards

The American Pharmacists Association (APhA) today announced the selection of recipients of the APhA Academy of Pharmacy Practice & Management Awards and APhA Academy of Pharmaceutical Research & Science Awards as part of the 2021 APhA Awards and Honors Program.

November 24, 2020

Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients

The country’s leading pharmacy groups issued the following statement on the Trump administration’s new final rule on prescription drug rebates.

Why APhA?

APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.